Presentation TCT 2016 European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI Presenter: David P. Faxon, C. Michael Gibson, Davide Capodanno November 01, 2016
Presentation TCT 2016 FDA Perspectives on Short DAPT IDE Trials Presenter: Michael C. John, Gregg W. Stone, Andrew Farb November 01, 2016
Presentation TCT 2016 What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT Presenter: David P. Faxon, C. Michael Gibson, Freek W.A. Verheugt November 01, 2016
Presentation TCT 2016 The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT Presenter: David P. Faxon, C. Michael Gibson, Christopher B. Granger November 01, 2016
Presentation TCT 2016 The Case for Surgery Presenter: Michael A. Borger, Vinod H. Thourani, Martin Misfeld November 01, 2016
Presentation TCT 2016 Case #3 - Resolution: Did We Close It (?), and Long-term Patient Outcomes Presenter: John D. Carroll, David E. Thaler, Michael J. Mullen November 01, 2016
Presentation TCT 2016 The Case for Transcatheter Therapy Presenter: Michael A. Borger, Vinod H. Thourani, Josep Rodés-Cabau November 01, 2016
News Conference News TCT 2016 ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 The Case for a Trial of Medical Therapy Presenter: John A. Bittl, David J. Maron, Michael E. Farkouh November 01, 2016
Presentation TCT 2016 Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy! Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen November 01, 2016
Presentation TCT 2016 Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, Ongoing Studies Presenter: George D. Dangas, Debabrata Mukherjee, C. Michael Gibson November 01, 2016
News Conference News TCT 2016 Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint Shelley Wood November 01, 2016
Presentation TCT 2016 TCT 320: The Results of T-Provisional and Mini Crush Stenting in Patients with Bifurcation Lesions After Recanalization of Chronic coronary Arteries Occlusions. Comparative Analysis Presenter: Michael A. Kutcher, Issam D. Moussa November 01, 2016
Presentation TCT 2016 TCT 319: Side Branch Mortality Score for Prediction of Five Year Mortality After Provisional Side Branch Coronary Bifurcation Stenting A New Tool Based on Intracoronary Electrocardiogram (iECG) From iECG and Myonecrosis After Bifurcation Stenting Presenter: Michael A. Kutcher, Issam D. Moussa November 01, 2016
Presentation TCT 2016 TCT 318: Ten-year All-cause Mortality After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study Presenter: Michael A. Kutcher, Issam D. Moussa November 01, 2016
Presentation TCT 2016 TEVAR New Devices for the Descending Thoracic Aorta Presenter: Brian G. DeRubertis, Grayson H. Wheatley, Michael D. Dake November 01, 2016
Presentation TCT 2016 TCT 403: Bioresorbable Coronary Devices in Bifurcations: Immediate and 6-month Results of the REPARA Registry Presenter: Michael A. Kutcher, Issam D. Moussa November 01, 2016
Presentation TCT 2016 Management of Aneurysmal Dilatation after Type B Dissection: Role of Branched Graft and Fenestrated Devices Presenter: Brian G. DeRubertis, Grayson H. Wheatley, Michael D. Dake November 01, 2016
Presentation TCT 2016 Long Term Outcomes after Revascularization of Long SFA Occlusions with OCT Guided Atherectomy OCELOT Catheter: Results from the Pivotal FIH Study Presenter: Michael D. Dake, Kenneth Rosenfield, Przemek Nowakowski November 01, 2016
Presentation TCT 2016 Safety and Performance of the Shockwave Medical Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-Phase DISRUPT PAD Study Presenter: Michael D. Dake, Kenneth Rosenfield, Todd J. Brinton November 01, 2016